Business
RenovaCare Highlights Clinical Results From 44 Severe Burn Patients Published in Medical Journal
RenovaCare Highlights Clinical Results From 44 Severe Burn Patients Published in Medical Journal.
About this update from Renovacare, Inc.
[{"type":"text","content":"\n \n RenovaCare, Inc., (OTCQB: RCAR), today highlighted an analysis of \n treatment results from 44 patients treated for severe second-degree \n wide-area burn injuries, as published in Burns, the peer-reviewed \n Journal of the International Society for Burn Injuries. The treatment \n method, which involved isolating and spraying the patient’s own skin \n stem cells on to burn wounds, is the technology underlying the \n RenovaCare patented SkinGun™* and CellMist™ System*.\n \n\nThis press release features multimedia. View the full release here: \nhttp://www.businesswire.com/news/home/20180130005343/en/\n\n \n \n Burn patients treated with technology behind RenovaCare SkinGun(TM). Source: Burns, Journal of the International Society for Burn Injuries. \n\n\n \n The results, published in the November 2017 issue of Burns, report the \n retrospective analysis of outcomes in 44 severe second-degree burn \n patients who received skin stem cell spray grafting treatment under an \n innovative practice approach.\n \n \n According to the Burns article, spraying deep partial-thickness burn \n wounds with a patient’s own skin stem cells “...can achieve rapid wound \n re-epithelialization, particularly in large wounds.” \n Re-epithelialization marks the final stage of successful healing and is \n an essential component of wound closure. At this stage, skin function is \n restored and the risk of infection is eliminated.\n \n \n “Treated patients presented with a variety of burn wound etiologies and \n a wide range of TBSA (Total Burn Surface Area). Overall clinical results \n were very satisfying,” stated the authors.\n \n \n Regardless of the severity or size of the wound, the average days of \n healing and discharge remained low. “The mean days to [hospital] \n discharge was 6.28 +/- 4.1 with a median of six days,” according to the \n study.\n \n \n “This data is especially compelling because patients were successfully \n treated for a broad spectrum of burn injuries and vast burn surface \n areas. Importantly, patients had very short hospital stays, which, we \n believe could deliver a better healing experience for patients and lower \n costs for hospitals and insurance providers,” stated Mr. Thomas Bold, \n President and CEO of RenovaCare, Inc.\n \n \n “The cl...